StockData
Protara Therapeutics, Inc. logo

Protara Therapeutics, Inc. (TARA) stock

TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$2.32−0.06 (-2.52%)

Close on Nov 17, 2026Market cap $137.10MP/E –Yield –

Protara Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Protara Therapeutics's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0–
FY2020Dec 31, 2020$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$0-100.0%
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$370.79K–
Q2 FY2020Jun 30, 2020$926.98K–
Q1 FY2020Mar 31, 2020$1.30M–

More Protara Therapeutics figures

See a number that looks wrong?